144 related articles for article (PubMed ID: 11782353)
1. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
[TBL] [Abstract][Full Text] [Related]
2. Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
Niho N; Mutoh M; Kitamura T; Takahashi M; Sato H; Yamamoto H; Maruyama T; Ohuchida S; Sugimura T; Wakabayashi K
Cancer Sci; 2005 May; 96(5):260-4. PubMed ID: 15904466
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
Kitamura T; Itoh M; Noda T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimura T; Wakabayashi K
Cancer Sci; 2003 Jul; 94(7):618-21. PubMed ID: 12841871
[TBL] [Abstract][Full Text] [Related]
4. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents.
Takahashi M; Wakabayashi K
Cancer Sci; 2004 Jun; 95(6):475-80. PubMed ID: 15182426
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea.
Niho N; Mutoh M; Sakano K; Takahashi M; Hirano S; Nukaya H; Sugimura T; Wakabayashi K
Cancer Sci; 2006 Apr; 97(4):248-51. PubMed ID: 16630115
[TBL] [Abstract][Full Text] [Related]
6. Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer.
Drew DA; Kim AE; Lin Y; Qu C; Morrison J; Lewinger JP; Kawaguchi E; Wang J; Fu Y; Zemlianskaia N; Díez-Obrero V; Bien SA; Dimou N; Albanes D; Baurley JW; Wu AH; Buchanan DD; Potter JD; Prentice RL; Harlid S; Arndt V; Barry EL; Berndt SI; Bouras E; Brenner H; Budiarto A; Burnett-Hartman A; Campbell PT; Carreras-Torres R; Casey G; Chang-Claude J; Conti DV; Devall MAM; Figueiredo JC; Gruber SB; Gsur A; Gunter MJ; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Kundaje A; Le Marchand L; Li L; Lynch BM; Murphy N; Nassir R; Newcomb PA; Newton CC; Obón-Santacana M; Ogino S; Ose J; Pai RK; Palmer JR; Papadimitriou N; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Rennert G; Ruiz-Narvaez E; Sakoda LC; Scacheri PC; Schmit SL; Schoen RE; Stern MC; Su YR; Thomas DC; Tian Y; Tsilidis KK; Ulrich CM; Um CY; van Duijnhoven FJB; Van Guelpen B; White E; Hsu L; Moreno V; Peters U; Chan AT; Gauderman WJ
Sci Adv; 2024 May; 10(22):eadk3121. PubMed ID: 38809988
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy.
Finetti F; Paradisi L; Bernardi C; Pannini M; Trabalzini L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190301
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.
Jin K; Qian C; Lin J; Liu B
Front Oncol; 2023; 13():1099811. PubMed ID: 36776289
[TBL] [Abstract][Full Text] [Related]
9. Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.
Feddersen UR; Hendel SK; Berner-Hansen MA; Jepps TA; Berner-Hansen M; Bindslev N
BMC Gastroenterol; 2022 May; 22(1):234. PubMed ID: 35549670
[TBL] [Abstract][Full Text] [Related]
10. Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer.
Wilson DJ; DuBois RN
Cancer Prev Res (Phila); 2022 Jun; 15(6):355-363. PubMed ID: 35288737
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.
Wang Q; Morris RJ; Bode AM; Zhang T
Cancer Res; 2022 Mar; 82(6):949-965. PubMed ID: 34949672
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
Shirakami Y; Nakanishi T; Ozawa N; Ideta T; Kochi T; Kubota M; Sakai H; Ibuka T; Tanaka T; Shimizu M
PLoS One; 2021; 16(5):e0251942. PubMed ID: 34003864
[TBL] [Abstract][Full Text] [Related]
13. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.
Wang B; Wu L; Chen J; Dong L; Chen C; Wen Z; Hu J; Fleming I; Wang DW
Signal Transduct Target Ther; 2021 Feb; 6(1):94. PubMed ID: 33637672
[TBL] [Abstract][Full Text] [Related]
14. miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells.
Monteleone NJ; Lutz CS
Oncotarget; 2020 Dec; 11(51):4699-4721. PubMed ID: 33473256
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue.
Jindal S; Pennock ND; Klug A; Narasimhan J; Calhoun A; Roberts MR; Tamimi RM; Eliassen AH; Weinmann S; Borges VF; Schedin P
NPJ Breast Cancer; 2020 Nov; 6(1):62. PubMed ID: 33298921
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity.
Finetti F; Travelli C; Ercoli J; Colombo G; Buoso E; Trabalzini L
Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33271839
[TBL] [Abstract][Full Text] [Related]
17. miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells.
Monteleone NJ; Lutz CS
Oncotarget; 2020 Jun; 11(26):2464-2483. PubMed ID: 32655834
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of prostaglandin EP4 receptor in three canine carcinomas.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
BMC Vet Res; 2020 Jun; 16(1):213. PubMed ID: 32571310
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.
Hidalgo-Estévez AM; Stamatakis K; Jiménez-Martínez M; López-Pérez R; Fresno M
Front Pharmacol; 2020; 11():533. PubMed ID: 32410997
[TBL] [Abstract][Full Text] [Related]
20. The Role of Cyclooxygenase-2 in Colorectal Cancer.
Sheng J; Sun H; Yu FB; Li B; Zhang Y; Zhu YT
Int J Med Sci; 2020; 17(8):1095-1101. PubMed ID: 32410839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
